<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS200764</article-id><article-id pub-id-type="doi">10.1101/2024.11.20.624489</article-id><article-id pub-id-type="archive">PPR944774</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Ancestry-specific gene expression in peripheral monocytes mediates risk of neurodegenerative disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wagen</surname><given-names>Aaron Z</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Reynolds</surname><given-names>Regina H</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Nee Foo</surname><given-names>Jia</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Fairbrother-Browne</surname><given-names>Aine</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gustavsson</surname><given-names>Emil K</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Galgiano-Turin</surname><given-names>Sarah</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>Nicholas W</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Blauwendraat</surname><given-names>Cornelis</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Gandhi</surname><given-names>Sonia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Ryten</surname><given-names>Mina</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A5">5</xref><xref ref-type="aff" rid="A7">7</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02jx3x895</institution-id><institution>University College London</institution></institution-wrap>, <city>London</city>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tnbqb63</institution-id><institution>The Francis Crick Institute</institution></institution-wrap>, <addr-line>1 Midland Road</addr-line>, <city>London</city>, <country country="GB">UK</country></aff><aff id="A3"><label>3</label>Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/048b34d51</institution-id><institution>Queen Square</institution></institution-wrap>, <city>London</city>, <country country="GB">UK</country></aff><aff id="A4"><label>4</label>Center for Alzheimer’s and Related Dementias, National Institute on Aging and <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01cwqze88</institution-id><institution>National Institutes of Health</institution></institution-wrap>, <city>Bethesda</city>, MD, <country country="US">USA</country></aff><aff id="A5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03zj4c476</institution-id><institution>Aligning Science Across Parkinson’s (ASAP)</institution></institution-wrap> Collaborative Research Network, <city>Chevy Chase</city>, <postal-code>MD 20815</postal-code>, <country country="US">USA</country></aff><aff id="A6"><label>6</label>Lee Kong Chian School of Medicine, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02e7b5302</institution-id><institution>Nanyang Technological University Singapore</institution></institution-wrap>, <addr-line>11 Mandalay Road</addr-line>, <city>Singapore</city><postal-code>308232</postal-code>, <country country="SG">Singapore</country></aff><aff id="A7"><label>7</label>Dementia Research Institute, Department of Clinical Neuroscience, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>Cambridge University</institution></institution-wrap>, <city>Cambridge</city><country country="GB">UK</country></aff><pub-date pub-type="nihms-submitted"><day>24</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>22</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">It is hypothesised that peripheral immune states responding to regional environmental triggers contribute to central neurodegeneration. Region-specific genetic selection pressures require this hypothesis to be assessed in an ancestry specific manner. Here we utilise genome-wide association studies and expression quantitative trait loci from African, East Asian and European ancestries to show that genes causing neurodegeneration are preferentially expressed in innate rather than adaptive immune cells, and that expression of these genes mediates the risk of neurodegenerative disease in monocytes in an ancestry-specific manner.</p></abstract></article-meta></front><body><p id="P2">The role of ancestry-specific risk is increasingly recognised in neurodegenerative diseases (NDDs). Rectifying the historical focus on European populations, recent efforts have explored the clinical and genetic diversity of conditions such as Alzheimer’s (AD) and Parkinson’s diseases (PD), and Frontotemporal dementia (FTD)<sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R4">4</xref></sup>. This includes appreciation of the differences in the prevalence and pathology of NDDs across populations<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref></sup>, as well as differences in the genetic architecture of both monogenic and complex forms of disease<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref>,<xref ref-type="bibr" rid="R7">7</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup>. Central to this has been the discovery of novel disease loci in ancestry-specific genome-wide association studies (GWAS) of NDDs<sup><xref ref-type="bibr" rid="R7">7</xref>–<xref ref-type="bibr" rid="R11">11</xref></sup>, and of variability of gene expression in post-mortem brains<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R12">12</xref></sup>. Despite these studies being limited by relatively small case numbers, they have identified novel risk loci with unexpectedly large effect sizes, emphasising the significant effect ancestry can have in neurodegeneration.</p><p id="P3">Simultaneously, the immune system is increasingly implicated in NDDs, including AD, PD and FTD. Within the CNS, the role of microglia, the parenchymal myeloid cells of the CNS, as well as immune related macro-glial states are gaining prominence<sup><xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R15">15</xref></sup>. Furthermore, both positron emission tomography (PET) based imaging approaches, as well as cerebrospinal fluid (CSF) biochemical analyses have demonstrated increases in inflammatory biomarkers in NDDs, with levels correlated to clinical outcomes. This central immune response is mirrored peripherally, and there is suggestive evidence that the peripheral response is fundamentally involved in disease pathogenesis<sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup>. Clinically, NDDs can commence with a peripheral prodrome, for example, anosmia and constipation in PD. Epidemiological data shows that NDDs have followed viral pandemics throughout history<sup><xref ref-type="bibr" rid="R18">18</xref></sup>, and that recent viral infection increases the risk of NDD<sup><xref ref-type="bibr" rid="R19">19</xref>,<xref ref-type="bibr" rid="R20">20</xref></sup>. Interestingly, this appears to occur without evidence of replicating viral particles, raising the possibility of a virally-triggered peripheral immune state that affects CNS function. Indeed, the concept of brain-immune crosstalk has been advanced with the potential to explain how environmental factors might contribute to neurodegenerative risk<sup><xref ref-type="bibr" rid="R21">21</xref></sup>, and underpinning recent therapeutic strategies to treat these diseases<sup><xref ref-type="bibr" rid="R22">22</xref>–<xref ref-type="bibr" rid="R24">24</xref></sup>.</p><p id="P4">In this work, we hypothesise that genes causally linked to AD, PD and FTD are themselves active in the peripheral immune response, and that this activity contributes to the risk of disease in an ancestry-specific manner. There is already some evidence to support this idea in PD, where studies in mice have shown that alpha-synuclein (<italic>SNCA</italic>), the major constituent of Lewy bodies and a cause of PD, has a protective role against viral infection centrally<sup><xref ref-type="bibr" rid="R25">25</xref></sup>, and can mediate antigen presentation and the inflammatory response in the peritoneum<sup><xref ref-type="bibr" rid="R26">26</xref></sup>. Similarly, common pathogenic variants in leucine-rich repeat kinase-2 (<italic>LRRK2</italic>) modulate inflammation in response to CNS and systemic infections<sup><xref ref-type="bibr" rid="R27">27</xref>,<xref ref-type="bibr" rid="R28">28</xref></sup>, as does a pathogenic <italic>GBA1</italic> variant with respect to viral encephalitis<sup><xref ref-type="bibr" rid="R29">29</xref></sup>. This association is also seen in AD and FTD, where, respectively, <italic>TREM2</italic><sup><xref ref-type="bibr" rid="R30">30</xref>,<xref ref-type="bibr" rid="R31">31</xref></sup> and <italic>C9orf72</italic><sup><xref ref-type="bibr" rid="R32">32</xref></sup> have peripheral immunomodulatory effects. Genetic analyses have linked the heritability of NDDs with peripheral immune cell types<sup><xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R34">34</xref></sup>. However, the risk of NDDs caused by the expression of genes in peripheral immune cells across diverse ancestries has not been investigated.</p><p id="P5">To study this, we systematically explored the role of 39 NDD genes causally implicated in AD, PD or FTD across peripheral immune cells (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table 1</xref>, <xref ref-type="sec" rid="S1">Methods</xref>). Given that both ancestry and activation state are well recognised to affect gene expression in peripheral immune cells, we used a multi-ancestry study of 22 different cell-types to study gene expression<sup><xref ref-type="bibr" rid="R35">35</xref></sup>. This dataset was derived from 222 African (n = 82), East Asian (n = 60) and European (n = 80) donors, either at baseline or after activation with SARS-CoV-2 or Influenza A viruses.</p><p id="P6">We found that 32 of the 39 NDD-causing genes (82%) were expressed across peripheral immune cells (<xref rid="F1" ref-type="fig">Figure 1a</xref>). Using phenotypic QTL data, we noted that 29 of these 32 genes (91%) were also causally associated with a white blood cell count metric in peripheral blood. Indeed, 20-83% of the NDD-causing genes, including <italic>APOE, SNCA</italic> and <italic>MAPT</italic>, were loci that influenced macrophage, monocyte, lymphocyte or total white cell count in at least one ancestry (<xref rid="F1" ref-type="fig">Figure 1b</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>).</p><p id="P7">Next, we explored the expression patterns of NDD-causing genes by cell type, activation state, and ancestry. Over 80% of these genes showed maximal expression in innate immune cell types, most commonly in monocytes (16 out of 34 cell types) and NK cells (8 out of 34 cell types, <xref rid="F1" ref-type="fig">Figure 1d</xref>). Genes with maximal expression in myeloid cell types (including <italic>APOE, PSEN1, TREM2, LRRK2</italic> and <italic>C9orf72</italic> in monocytes; and <italic>APP</italic> and <italic>PSEN2</italic> in dendritic cells) showed greatest cell-type specificity (mean τ-statistic = 0.82, <xref rid="F1" ref-type="fig">Figure 1e</xref>). In contrast, genes with maximal expression in NK cells were more broadly expressed (mean τ-statistic 0.63, p value for two sample T-test = 0.01). Three NDD genes (<italic>TREM2, APOE</italic> and <italic>LRRK2</italic>) showed high specificity (τ-statistic &gt; 0.9) to unstimulated activation states as compared to those treated with influenza or SARS-CoV-2 (<xref rid="F1" ref-type="fig">Figure 1f</xref>). Notably, these three genes all had maximal expression in monocytes. Myeloid cells also showed the greatest number of genes differentially expressed across ancestries (European relative to African ancestry) with 10 genes identified, including <italic>APP, BIN1, GBA1, RAB32, C9orf72</italic> and <italic>GRN</italic> (<xref rid="F1" ref-type="fig">Figure 1c</xref>). Taken together, these results show that genes central to NDDs are preferentially expressed in peripheral immune cells of myeloid lineage, and that these cells contain the greatest proportion of cell type- and ancestry-specific NDD gene expression.</p><p id="P8">We then explored whether the expression of these genes in the periphery might be causally linked with disease. To do this, we applied a well-established genetic approach, colocalisation analysis, to explore the possibility that NDD gene expression in the peripheral immune system might be a driver of disease risk<sup><xref ref-type="bibr" rid="R36">36</xref></sup>. This analysis uses a Bayesian approach to ascertain the posterior probabilities that association signals of two traits at a genetic locus share a causal variant (posterior probability of hypothesis 4, PPH4), or whether these association signals are distinct (posterior probability of hypothesis 3, PPH3, <xref ref-type="sec" rid="S1">Methods</xref>). Crucially, these analyses were conducted in an ancestry-specific manner, as we reasoned that the peripheral immune system would be the first to encounter geographically restricted microbes and pollutants, leading to variable environmental selection pressures<sup><xref ref-type="bibr" rid="R37">37</xref></sup>. This required use of very recently produced ancestry-specific GWAS, as well as corresponding ancestry-aware functional genomic annotations, namely expression quantitative trait loci (eQTL). We utilised the eQTL available from the same multi-ancestry study used to explore gene expression above, due to the availability of data across multiple populations, cell types and activation states<sup><xref ref-type="bibr" rid="R35">35</xref></sup>.</p><p id="P9">We first explored ancestry-specific AD GWASs with multi-ancestry eQTL data. When using a European AD GWAS<sup><xref ref-type="bibr" rid="R38">38</xref></sup>, we identified a colocalising signal in <italic>BIN1</italic> in monocytes (PPH4 = 0.93, <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 2</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. 2</xref>). There was a positive correlation between effect sizes of the GWAS and eQTL single nucleotide polymorphisms (SNPs) at this locus, suggesting that increased <italic>BIN1</italic> expression in peripheral monocytes correlated with increased risk of AD. While the role of <italic>BIN1</italic> in modulating AD is known within the CNS<sup><xref ref-type="bibr" rid="R39">39</xref></sup>, this result suggests a causative role for the gene in AD the periphery. Noting that <italic>BIN1</italic> is not a significant locus in the East Asian AD GWAS<sup><xref ref-type="bibr" rid="R11">11</xref></sup>, we found no colocalising signal at BIN1 when this GWAS was tested against the multi-ancestry eQTL (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table 3</xref>).</p><p id="P10">Focusing on PD, with a GWAS derived from individuals of European ancestry<sup><xref ref-type="bibr" rid="R40">40</xref></sup>, we identified a colocalising signal within the PD-associated gene <italic>LRRK2</italic>, mediating the risk of PD and gene expression in SARS-CoV-2-treated CD14 monocytes (<xref rid="F2" ref-type="fig">Figure 2a</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 4</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>). To check whether this result was ancestry specific, we undertook the same analysis with an East Asian PD GWAS<sup><xref ref-type="bibr" rid="R9">9</xref></sup>, finding that the result was underpowered at this locus (PPH3 + PPH4 &lt; 0.75, <xref rid="F2" ref-type="fig">Figure 2a</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 5</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 4</xref>, <xref ref-type="sec" rid="S1">Methods</xref>). Given this, we checked the East Asian GWAS against an East-Asian-specific eQTL dataset<sup><xref ref-type="bibr" rid="R41">41</xref></sup>, finding the association signals underlying <italic>LRRK2</italic> expression in monocytes were distinct from those underlying PD risk in all monocyte cell types tested (PPH3 &gt;0.99, <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 6</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 5</xref>).</p><p id="P11">Focusing on the <italic>SNCA</italic> locus, arguably the most important gene in PD, there was insufficient power when the multi-ancestry eQTL was tested against both the European and East Asian PD GWASs (PPH4 + PPH3 &lt; 0.75, <xref rid="F2" ref-type="fig">Figure 2a</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 4, 5</xref>). However, noting that the PPH4/PPH3 ratio was high at 3.5, we checked this locus using an East-Asian-specific PD eQTL and GWAS. We found that in this East-Asian-specific analysis that there was a significant colocalisation in <italic>SNCA</italic> expression in CD16+ monocytes (<xref rid="F2" ref-type="fig">Figure 2b</xref>, <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 6</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 5</xref>). Using the multi-ancestry eQTL with an African PD GWAS, there was a suggestive but underpowered colocalising signal at BIN1 in CD14+ monocytes (PPH4=0.71, PPH3+PPH4=0.73, PPH4/PPH3 ratio=39.9). We could not validate this result in an African-specific eQTL dataset given the lack of power in the available datasets (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table 8</xref>).</p><p id="P12">As expected, at the <italic>LRRK2</italic> locus, there was a positive correlation between effect sizes in European populations, implying that increased <italic>LRRK2</italic> expression associates with increased PD risk (<xref rid="F2" ref-type="fig">Figure 2b</xref>). In contrast,at the <italic>SNCA</italic> locus in East Asian populations, the correlation between effect sizes was negative, suggesting that decreased <italic>SNCA</italic> expression in CD16+ monocytes was associated with increased PD risk. While this result appears to be counter-intuitive given that increased <italic>SNCA</italic> in the CNS is associated with PD, this finding is in keeping with multiple existing genomic and proteomic studies, which show that PD is associated with a decreased <italic>SNCA</italic> RNA and protein in blood and CSF<sup><xref ref-type="bibr" rid="R33">33</xref>,<xref ref-type="bibr" rid="R42">42</xref>–<xref ref-type="bibr" rid="R44">44</xref></sup>.</p><p id="P13">In summary, we show that genes causally implicated in NDDs mediate the risk of these diseases partially through effects in the peripheral immune system. Crucially, the expression of these genes as well as the risk mediated by them were ancestry dependent. This suggests not only that neurodegeneration has a peripheral component, but that across different ancestries regional selection pressures may have differentially modulated disease mechanisms. The results also suggest that genes that have a detrimental effect within the CNS may be protective peripherally<sup><xref ref-type="bibr" rid="R25">25</xref>,<xref ref-type="bibr" rid="R26">26</xref></sup>. In addition to emphasising the importance of ancestry-specific functional genetic annotations, this work defines innate immune cells, and specifically monocytes, as potential targets for treatments for neurodegeneration.</p><sec id="S1" sec-type="methods"><title>Methods</title><sec id="S2"><title>Neurodegenerative gene list curation</title><p id="P14">Genes causally implicated in AD were identified as described by Neuner et al<sup><xref ref-type="bibr" rid="R45">45</xref></sup>, selecting the 18 genes with increased confidence of causation. Fourteen genes causally implicated in PD with high or very high confidence were selected as reported by Blauwendraat et al<sup><xref ref-type="bibr" rid="R46">46</xref></sup>, with the addition of <italic>RAB32</italic> whose role in PD has recently emerged<sup><xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R48">48</xref></sup>. Causative FTD genes were selected from Antionioni et al<sup><xref ref-type="bibr" rid="R49">49</xref></sup>, including the 6 genes that contribute ≥1% of disease frequency.</p></sec><sec id="S3"><title>eQTL preprocessing</title><p id="P15">We systematically searched PubMed for eQTL studies of peripheral blood from the last 10 years with the following features: i) included more than 150 participants; ii) specifically stated ancestry; iii) divided cells into clearly defined subtypes by single cell sequencing or cytometric approaches; and iv) included an activation state generated either with an immunogenic trigger or through the inclusion of participants with immunological disease. The Aquino et al dataset<sup><xref ref-type="bibr" rid="R35">35</xref></sup> was the only dataset identified that included participants from African, Asian and European ancestry. Noting that it analysed 22 different cell types, and included activation state data with samples stimulated with either SARS-CoV-2 virus or influenza A virus, it was selected as the baseline dataset for this study. For colocalisation analyses, the Aquino et al dataset was supplemented by use of Ota et al<sup><xref ref-type="bibr" rid="R41">41</xref></sup>, as a large dataset specific to East Asian ancestry. The only African-specific ancestry eQTLs that were identified included two datasets from African and African admixed populations, one exploring monocytes<sup><xref ref-type="bibr" rid="R50">50</xref></sup>, and the other macrophages<sup><xref ref-type="bibr" rid="R51">51</xref></sup>.</p><p id="P16">Where relevant, summary statistics were processed by lifting over genomic locations from GRCh37 to GRCh38. SNP genomic coordinates were mapped to Reference SNP cluster IDs (rsIDs) using the SNPlocs.Hsapiens.dbSNP144.GRCh38 package, and ancestry-specific minor allele frequencies were imported from the MafDb.1Kgenomes.phase3.GRCh38 package<sup><xref ref-type="bibr" rid="R52">52</xref></sup>.</p></sec><sec id="S4"><title>Blood count phenotype-QTL processing</title><p id="P17">Significant associations between genetic variation and blood count metrics were derived from a multi-ancestry phenotype QTL<sup><xref ref-type="bibr" rid="R53">53</xref></sup>. Significant traits between blood cell metrics of interest (neutrophil, lymphocyte, monocyte and total white blood cell count) and NDD genes were exported using Open Targets (<ext-link ext-link-type="uri" xlink:href="https://genetics.opentargets.org/">https://genetics.opentargets.org/</ext-link>, RRID:SCR_014622)<sup><xref ref-type="bibr" rid="R54">54</xref></sup>.</p></sec><sec id="S5"><title>Gene expression analysis</title><p id="P18">The gene expression and differential gene expression datasets used in this study were generated by Aquino et al<sup><xref ref-type="bibr" rid="R35">35</xref></sup>. To facilitate comparison between cell types, the raw transcript per million (TPM) for each gene was normalised by the maximum TPM per gene across cell types and activation states, giving the metric of proportion of expression per gene. Noting that cells in Aquino et al were treated with both influenza A and SARS-CoV-2 viruses, this was also normalised using the above approach. Of each cell type that showed maximal expression of a gene, the maximal cell state was defined as the viral exposure that resulted in the maximal expression of the gene for that celltype.</p><p id="P19">To measure the cell-type specificity of gene expression, the τ-statistic was calculated using the method defined by Yanai et al<sup><xref ref-type="bibr" rid="R55">55</xref></sup>: <disp-formula id="FD1"><mml:math id="M1"><mml:mrow><mml:mi>τ</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula> where N is the number of tissues and x<sub>i</sub> is the expression profile component normalised by the maximal component value. For each cell type that contained the highest expression per gene, a further τ-statistic was calculated to measure cell-state specificity of response to viral stimulation.</p><p id="P20">Differential gene expression analysis results were utilised from Aquino et al. They compared European relative to African populations using a linear regression model, adjusted for individual donor age, cellular mortality and cellular composition as described<sup><xref ref-type="bibr" rid="R35">35</xref></sup>.</p></sec><sec id="S6"><title>GWAS preprocessing</title><p id="P21">GWAS summary statistics from 3 ancestry-specific studies of PD were used: European<sup><xref ref-type="bibr" rid="R40">40</xref></sup>, African<sup><xref ref-type="bibr" rid="R10">10</xref></sup>, and East Asian<sup><xref ref-type="bibr" rid="R9">9</xref></sup> ancestry. Two ancestry-specific GWAS studies were used for AD: European<sup><xref ref-type="bibr" rid="R38">38</xref></sup> and Asian<sup><xref ref-type="bibr" rid="R11">11</xref></sup>. Where relevant, summary statistics were processed by lifting over genomic locations from GRCh37 to GRCh38. SNP genomic coordinates were mapped to rsIDs using the SNPlocs.Hsapiens.dbSNP144.GRCh38 package (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/data/annotation/html/SNPlocs.Hsapiens.dbSNP144.GRCh38.html">https://bioconductor.org/packages/release/data/annotation/html/SNPlocs.Hsapiens.dbSNP144.GRCh38.html</ext-link>)<sup><xref ref-type="bibr" rid="R56">56</xref></sup>, and ancestry-specific minor allele frequencies were imported from the MafDb.1Kgenomes.phase3.GRCh38 package (<ext-link ext-link-type="uri" xlink:href="https://www.bioconductor.org/packages/release/data/annotation/html/MafDb.1Kgenomes.phase3.GRCh38.html">https://www.bioconductor.org/packages/release/data/annotation/html/MafDb.1Kgenomes.phase3.GRCh38.html</ext-link>)<sup><xref ref-type="bibr" rid="R52">52</xref></sup>.</p></sec><sec id="S7"><title>Colocalisation analysis</title><p id="P22">To evaluate the probability that GWAS loci and eQTLs share a single causal variant, a colocalisation analysis was performed using coloc (version 5.1.0.1, <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=coloc">https://cran.r-project.org/package=coloc</ext-link>) and colochelpR (version 0.99.1, <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5281/zenodo.5011869">http://dx.doi.org/10.5281/zenodo.5011869</ext-link>)<sup><xref ref-type="bibr" rid="R36">36</xref>,<xref ref-type="bibr" rid="R57">57</xref></sup>. GWAS loci within 1 Mb significant GWAS SNPs were explored. The prior probability that any random SNP in the region is associated with the GWAS (p<sub>1</sub>) or eQTL (p<sub>2</sub>) was set to the default 10<sup>−4</sup>, whereas the prior probability that any random SNP in the region is associated with both traits (p<sub>12</sub>) was set to 10<sup>−5</sup>. Using a Bayesian approach, posterior probabilities were calculated for four different hypotheses that together sum to 1. Hypothesis 1 and 2 measure associations of the GWAS locus or the eQTL locus, where there is no sufficient power in the two studies to compare the two (as defined by PPH4 + PPH3 &lt; 0.75). Hypothesis 3 (PPH3) measures the probability that the traits have distinct causal variants at a locus, while hypothesis 4 (PPH4) measures the probability that a locus is colocalised as a result of a single causal variant.</p></sec><sec id="S8"><title>Statistical analysis</title><p id="P23">All statistical analysis was undertaken in R version 4.2.0 (RRID:SCR_001905, <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>).</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary materials</label><media xlink:href="EMS200764-supplement-Supplementary_materials.pdf" mimetype="application" mime-subtype="pdf" id="d2aAcNbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary tables</label><media xlink:href="EMS200764-supplement-Supplementary_tables.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d2aAcNcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S9"><title>Acknowledgements</title><p>This research was funded in part by Aligning Science Across Parkinson’s [ASAP-000509 and ASAP-000463] through the Michael J. Fox Foundation for Parkinson’s Research (MJFF). This work utilized the computational resources of the NIH HPC Biowulf cluster (<ext-link ext-link-type="uri" xlink:href="https://hpc.nih.gov/">http://hpc.nih.gov</ext-link>). This work was supported in part by the Intramural Research Program of the National Institutes of Health including: the Center for Alzheimer’s and Related Dementias, within the Intramural Research Program of the National Institute on Aging and the National Institute of Neurological Disorders and Stroke.</p><p>AZW was supported through the award of a Clinical Research Fellowship funded by the Wolfson Foundation and Eisai Ltd. SG was supported by Wellcome (100172/Z/12/2) and is currently an MRC Senior Clinical Fellow (MR/T008199/1). MR was supported by the UK Medical Research Council (MRC) through her award of Tenure-track Clinician Scientist Fellowship (MR/N008324/1).</p></ack><sec id="S10" sec-type="data-availability"><title>Code availability</title><p id="P24">The complete code utilised in this work can be accessed at <ext-link ext-link-type="uri" xlink:href="https://github.com/aaronwagen/peripheral_immune_neurodegeneration">https://github.com/aaronwagen/peripheral_immune_neurodegeneration</ext-link>, including knitted markdowns with integrated analysis, results, and packages utilised.</p><sec id="S11" sec-type="data-availability"><title>Data availability</title><p id="P25">Summary statistics for Foo et al, Rizig et al and Shigemizu et al were supplied by the authors. Otherwise, all datasets utilised are from public sources (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table 9</xref>).</p></sec></sec><fn-group><fn id="FN1" fn-type="conflict"><p id="P26"><bold>Competing interests</bold></p><p id="P27">RHR is currently employed by CoSyne Therapeutics (Lead Computational Biologist). All work performed for this publication was performed in her own time, and not as a part of her duties as an employee.</p></fn></fn-group><ref-list><title>Bibliography</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The epidemiology of Parkinson’s disease</article-title><source>The Lancet</source><year>2024</year><volume>403</volume><fpage>283</fpage><lpage>292</lpage></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehghani</surname><given-names>N</given-names></name><name><surname>Bras</surname><given-names>J</given-names></name><name><surname>Guerreiro</surname><given-names>R</given-names></name></person-group><article-title>How understudied populations have contributed to our understanding of Alzheimer’s disease genetics</article-title><source>Brain</source><year>2021</year><volume>144</volume><fpage>1067</fpage><lpage>1081</lpage><pub-id pub-id-type="pmcid">PMC8105043</pub-id><pub-id pub-id-type="pmid">33889936</pub-id><pub-id pub-id-type="doi">10.1093/brain/awab028</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koros</surname><given-names>C</given-names></name><etal/></person-group><article-title>The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review</article-title><source>Genes</source><year>2023</year><volume>14</volume><fpage>2097</fpage><pub-id pub-id-type="pmcid">PMC10671808</pub-id><pub-id pub-id-type="pmid">38003040</pub-id><pub-id pub-id-type="doi">10.3390/genes14112097</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reitz</surname><given-names>C</given-names></name><name><surname>Pericak-Vance</surname><given-names>MA</given-names></name><name><surname>Foroud</surname><given-names>T</given-names></name><name><surname>Mayeux</surname><given-names>R</given-names></name></person-group><article-title>A global view of the genetic basis of Alzheimer disease</article-title><source>Nat Rev Neurol</source><year>2023</year><volume>19</volume><fpage>261</fpage><lpage>277</lpage><pub-id pub-id-type="pmcid">PMC10686263</pub-id><pub-id pub-id-type="pmid">37024647</pub-id><pub-id pub-id-type="doi">10.1038/s41582-023-00789-z</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naslavsky</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample</article-title><source>Mol Psychiatry</source><year>2022</year><volume>27</volume><fpage>4800</fpage><lpage>4808</lpage><pub-id pub-id-type="pmcid">PMC9734036</pub-id><pub-id pub-id-type="pmid">36071110</pub-id><pub-id pub-id-type="doi">10.1038/s41380-022-01729-x</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlesinger</surname><given-names>D</given-names></name><etal/></person-group><article-title>African ancestry protects against Alzheimer’s disease-related neuropathology</article-title><source>Mol Psychiatry</source><year>2013</year><volume>18</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="pmcid">PMC3526728</pub-id><pub-id pub-id-type="pmid">22064377</pub-id><pub-id pub-id-type="doi">10.1038/mp.2011.136</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease</article-title><source>Nat Genet</source><year>2024</year><volume>56</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="pmcid">PMC10786718</pub-id><pub-id pub-id-type="pmid">38155330</pub-id><pub-id pub-id-type="doi">10.1038/s41588-023-01584-8</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lake</surname><given-names>J</given-names></name><etal/></person-group><article-title>Multi-ancestry meta-analysis and fine-mapping in Alzheimer’s disease</article-title><source>Mol Psychiatry</source><year>2023</year><volume>28</volume><fpage>3121</fpage><lpage>3132</lpage><pub-id pub-id-type="pmcid">PMC10615750</pub-id><pub-id pub-id-type="pmid">37198259</pub-id><pub-id pub-id-type="doi">10.1038/s41380-023-02089-w</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foo</surname><given-names>JN</given-names></name><etal/></person-group><article-title>Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study</article-title><source>JAMA Neurol</source><year>2020</year><volume>77</volume><fpage>746</fpage><lpage>754</lpage><pub-id pub-id-type="pmcid">PMC7171584</pub-id><pub-id pub-id-type="pmid">32310270</pub-id><pub-id pub-id-type="doi">10.1001/jamaneurol.2020.0428</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizig</surname><given-names>M</given-names></name><etal/></person-group><article-title>Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson’s Disease in African and African Admixed Populations</article-title><source>medRxiv</source><year>2023</year><elocation-id>2023.05.05.23289529</elocation-id><pub-id pub-id-type="doi">10.1101/2023.05.05.23289529</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shigemizu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk</article-title><source>Transl Psychiatry</source><year>2021</year><volume>11</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmcid">PMC7925686</pub-id><pub-id pub-id-type="pmid">33654092</pub-id><pub-id pub-id-type="doi">10.1038/s41398-021-01272-3</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>KJM</given-names></name><etal/></person-group><article-title>Analysis of gene expression in the postmortem brain of neurotypical Black Americans reveals contributions of genetic ancestry</article-title><source>Nat Neurosci</source><year>2024</year><volume>27</volume><fpage>1064</fpage><lpage>1074</lpage><pub-id pub-id-type="pmcid">PMC11156587</pub-id><pub-id pub-id-type="pmid">38769152</pub-id><pub-id pub-id-type="doi">10.1038/s41593-024-01636-0</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartels</surname><given-names>T</given-names></name><name><surname>De Schepper</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name></person-group><article-title>Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseases</article-title><source>Science</source><year>2020</year><volume>370</volume><fpage>66</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">33004513</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadick</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer’s disease</article-title><source>Neuron</source><year>2022</year><volume>110</volume><fpage>1788</fpage><lpage>1805</lpage><elocation-id>e10</elocation-id><pub-id pub-id-type="pmcid">PMC9167747</pub-id><pub-id pub-id-type="pmid">35381189</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2022.03.008</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Sa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Alpha-synuclein aggregates trigger anti-viral immune pathways and RNA editing in human astrocytes</article-title><year>2024</year><elocation-id>2024.02.26.582055</elocation-id><comment>Preprint at</comment><pub-id pub-id-type="doi">10.1101/2024.02.26.582055</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berriat</surname><given-names>F</given-names></name><name><surname>Lobsiger</surname><given-names>CS</given-names></name><name><surname>Boillée</surname><given-names>S</given-names></name></person-group><article-title>The contribution of the peripheral immune system to neurodegeneration</article-title><source>Nat Neurosci</source><year>2023</year><volume>26</volume><fpage>942</fpage><lpage>954</lpage><pub-id pub-id-type="pmid">37231108</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellani</surname><given-names>G</given-names></name><name><surname>Croese</surname><given-names>T</given-names></name><name><surname>Peralta Ramos</surname><given-names>JM</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name></person-group><article-title>Transforming the understanding of brain immunity</article-title><source>Science</source><year>2023</year><volume>380</volume><elocation-id>eabo7649</elocation-id><pub-id pub-id-type="pmid">37023203</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limphaibool</surname><given-names>N</given-names></name><name><surname>Iwanowski</surname><given-names>P</given-names></name><name><surname>Holstad</surname><given-names>MJV</given-names></name><name><surname>Kobylarek</surname><given-names>D</given-names></name><name><surname>Kozubski</surname><given-names>W</given-names></name></person-group><article-title>Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications</article-title><source>Front Neurol</source><year>2019</year><volume>10</volume><pub-id pub-id-type="pmcid">PMC6593078</pub-id><pub-id pub-id-type="pmid">31275235</pub-id><pub-id pub-id-type="doi">10.3389/fneur.2019.00652</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kettunen</surname><given-names>P</given-names></name><name><surname>Koistinaho</surname><given-names>J</given-names></name><name><surname>Rolova</surname><given-names>T</given-names></name></person-group><article-title>Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review</article-title><source>J Neuroinflammation</source><year>2024</year><volume>21</volume><fpage>152</fpage><pub-id pub-id-type="pmcid">PMC11157808</pub-id><pub-id pub-id-type="pmid">38845026</pub-id><pub-id pub-id-type="doi">10.1186/s12974-024-03139-y</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Virus exposure and neurodegenerative disease risk across national biobanks</article-title><source>Neuron</source><year>2023</year><volume>111</volume><fpage>1086</fpage><lpage>1093</lpage><elocation-id>e2</elocation-id><pub-id pub-id-type="pmcid">PMC10079561</pub-id><pub-id pub-id-type="pmid">36669485</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2022.12.029</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>M</given-names></name><name><surname>Deczkowska</surname><given-names>A</given-names></name></person-group><article-title>Neurological Disease as a Failure of Brain–Immune Crosstalk: The Multiple Faces of Neuroinflammation</article-title><source>Trends Immunol</source><year>2016</year><volume>37</volume><fpage>668</fpage><lpage>679</lpage><pub-id pub-id-type="pmid">27616557</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenzweig</surname><given-names>N</given-names></name><etal/></person-group><article-title>PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>465</elocation-id><pub-id pub-id-type="pmcid">PMC6349941</pub-id><pub-id pub-id-type="pmid">30692527</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-08352-5</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarazin</surname><given-names>M</given-names></name><etal/></person-group><article-title>The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer’s disease</article-title><source>Nat Aging</source><year>2024</year><volume>4</volume><fpage>761</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">38839924</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>M</given-names></name></person-group><article-title>Can immunotherapy treat neurodegeneration?</article-title><source>Science</source><year>2017</year><volume>357</volume><fpage>254</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">28729500</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beatman</surname><given-names>EL</given-names></name><etal/></person-group><article-title>Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain</article-title><source>J Virol</source><year>2015</year><volume>90</volume><fpage>2767</fpage><lpage>2782</lpage><pub-id pub-id-type="pmcid">PMC4810656</pub-id><pub-id pub-id-type="pmid">26719256</pub-id><pub-id pub-id-type="doi">10.1128/JVI.02949-15</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function</article-title><source>Cell Rep</source><year>2022</year><volume>38</volume><elocation-id>110090</elocation-id><pub-id pub-id-type="pmcid">PMC10258816</pub-id><pub-id pub-id-type="pmid">35021075</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.110090</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shutinoski</surname><given-names>B</given-names></name><etal/></person-group><article-title>Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner</article-title><source>Sci Transl Med</source><year>2019</year><volume>11</volume><elocation-id>eaas9292</elocation-id><pub-id pub-id-type="pmid">31554740</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fava</surname><given-names>VM</given-names></name><etal/></person-group><article-title>Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson’s disease</article-title><source>Proc Natl Acad Sci</source><year>2019</year><volume>116</volume><fpage>15616</fpage><lpage>15624</lpage><pub-id pub-id-type="pmcid">PMC6681704</pub-id><pub-id pub-id-type="pmid">31308240</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1901805116</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melamed</surname><given-names>S</given-names></name><etal/></person-group><article-title>Innate immune response in neuronopathic forms of Gaucher disease confers resistance against viral-induced encephalitis</article-title><source>Acta Neuropathol Commun</source><year>2020</year><volume>8</volume><fpage>144</fpage><pub-id pub-id-type="pmcid">PMC7443817</pub-id><pub-id pub-id-type="pmid">32831144</pub-id><pub-id pub-id-type="doi">10.1186/s40478-020-01020-6</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griciuc</surname><given-names>A</given-names></name><name><surname>Tanzi</surname><given-names>RE</given-names></name></person-group><article-title>The role of innate immune genes in Alzheimer’s disease</article-title><source>Curr Opin Neurol</source><year>2021</year><volume>34</volume><fpage>228</fpage><pub-id pub-id-type="pmcid">PMC7954128</pub-id><pub-id pub-id-type="pmid">33560670</pub-id><pub-id pub-id-type="doi">10.1097/WCO.0000000000000911</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matos</surname><given-names>Ade O</given-names></name><name><surname>Dantas</surname><given-names>PHdosS</given-names></name><name><surname>Queiroz</surname><given-names>HAGdeB</given-names></name><name><surname>Silva-Sales</surname><given-names>M</given-names></name><name><surname>Sales-Campos</surname><given-names>H</given-names></name></person-group><article-title>TREM-2: friend or foe in infectious diseases?</article-title><source>Crit Rev Microbiol</source><year>2024</year><volume>50</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">36403150</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCauley</surname><given-names>ME</given-names></name><etal/></person-group><article-title>C9orf72 in myeloid cells suppresses STING-induced inflammation</article-title><source>Nature</source><year>2020</year><volume>585</volume><fpage>96</fpage><lpage>101</lpage><pub-id pub-id-type="pmcid">PMC7484469</pub-id><pub-id pub-id-type="pmid">32814898</pub-id><pub-id pub-id-type="doi">10.1038/s41586-020-2625-x</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases</article-title><source>Npj Park Dis</source><year>2023</year><volume>9</volume><fpage>70</fpage><pub-id pub-id-type="pmcid">PMC10147945</pub-id><pub-id pub-id-type="pmid">37117178</pub-id><pub-id pub-id-type="doi">10.1038/s41531-023-00504-1</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lona-Durazo</surname><given-names>F</given-names></name><name><surname>Reynolds</surname><given-names>RH</given-names></name><name><surname>Scholz</surname><given-names>SW</given-names></name><name><surname>Ryten</surname><given-names>M</given-names></name><name><surname>Gagliano Taliun</surname><given-names>SA</given-names></name></person-group><article-title>Regional genetic correlations highlight relationships between neurodegenerative disease loci and the immune system</article-title><source>Commun Biol</source><year>2023</year><volume>6</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmcid">PMC10349864</pub-id><pub-id pub-id-type="pmid">37454237</pub-id><pub-id pub-id-type="doi">10.1038/s42003-023-05113-5</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquino</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dissecting human population variation in single-cell responses to SARS-CoV-2</article-title><source>Nature</source><year>2023</year><volume>621</volume><fpage>120</fpage><lpage>128</lpage><pub-id pub-id-type="pmcid">PMC10482701</pub-id><pub-id pub-id-type="pmid">37558883</pub-id><pub-id pub-id-type="doi">10.1038/s41586-023-06422-9</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>C</given-names></name></person-group><article-title>Eliciting priors and relaxing the single causal variant assumption in colocalisation analyses</article-title><source>PLoS Genet</source><year>2020</year><volume>16</volume><elocation-id>e1008720</elocation-id><pub-id pub-id-type="pmcid">PMC7192519</pub-id><pub-id pub-id-type="pmid">32310995</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008720</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodin</surname><given-names>P</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name></person-group><article-title>Human immune system variation</article-title><source>Nat Rev Immunol</source><year>2017</year><volume>17</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="pmcid">PMC5328245</pub-id><pub-id pub-id-type="pmid">27916977</pub-id><pub-id pub-id-type="doi">10.1038/nri.2016.125</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>IE</given-names></name><etal/></person-group><article-title>Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk</article-title><source>Nat Genet</source><year>2019</year><volume>51</volume><fpage>404</fpage><lpage>413</lpage><pub-id pub-id-type="pmcid">PMC6836675</pub-id><pub-id pub-id-type="pmid">30617256</pub-id><pub-id pub-id-type="doi">10.1038/s41588-018-0311-9</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudwarts</surname><given-names>A</given-names></name><etal/></person-group><article-title>BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia</article-title><source>Mol Neurodegener</source><year>2022</year><volume>17</volume><fpage>33</fpage><pub-id pub-id-type="pmcid">PMC9077874</pub-id><pub-id pub-id-type="pmid">35526014</pub-id><pub-id pub-id-type="doi">10.1186/s13024-022-00535-x</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nalls</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies</article-title><source>Lancet Neurol</source><year>2019</year><volume>18</volume><fpage>1091</fpage><lpage>1102</lpage><pub-id pub-id-type="pmcid">PMC8422160</pub-id><pub-id pub-id-type="pmid">31701892</pub-id><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30320-5</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>3006</fpage><lpage>3021</lpage><elocation-id>e17</elocation-id><pub-id pub-id-type="pmid">33930287</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>DW</given-names></name><etal/></person-group><article-title>RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s disease</article-title><source>Nat Aging</source><year>2021</year><volume>1</volume><fpage>734</fpage><lpage>747</lpage><pub-id pub-id-type="pmid">37117765</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irmady</surname><given-names>K</given-names></name><etal/></person-group><article-title>Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson’s disease</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><elocation-id>3956</elocation-id><pub-id pub-id-type="pmcid">PMC10322907</pub-id><pub-id pub-id-type="pmid">37407548</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-39652-6</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollenhauer</surname><given-names>B</given-names></name><etal/></person-group><article-title>α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study</article-title><source>Lancet Neurol</source><year>2011</year><volume>10</volume><fpage>230</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">21317042</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neuner</surname><given-names>SM</given-names></name><name><surname>Tcw</surname><given-names>J</given-names></name><name><surname>Goate</surname><given-names>AM</given-names></name></person-group><article-title>Genetic architecture of Alzheimer’s disease</article-title><source>Neurobiol Dis</source><year>2020</year><volume>143</volume><elocation-id>104976</elocation-id><pub-id pub-id-type="pmcid">PMC7409822</pub-id><pub-id pub-id-type="pmid">32565066</pub-id><pub-id pub-id-type="doi">10.1016/j.nbd.2020.104976</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blauwendraat</surname><given-names>C</given-names></name><name><surname>Nalls</surname><given-names>MA</given-names></name><name><surname>Singleton</surname><given-names>AB</given-names></name></person-group><article-title>The genetic architecture of Parkinson’s disease</article-title><source>Lancet Neurol</source><year>2020</year><volume>19</volume><fpage>170</fpage><lpage>178</lpage></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gustavsson</surname><given-names>EK</given-names></name><etal/></person-group><article-title>RAB32 Ser71Arg in autosomal dominant Parkinson’s disease: linkage, association, and functional analyses</article-title><source>Lancet Neurol</source><year>2024</year><volume>23</volume><fpage>603</fpage><lpage>614</lpage><pub-id pub-id-type="pmcid">PMC11096864</pub-id><pub-id pub-id-type="pmid">38614108</pub-id><pub-id pub-id-type="doi">10.1016/S1474-4422(24)00121-2</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hop</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease</article-title><source>Nat Genet</source><year>2024</year><volume>56</volume><fpage>1371</fpage><lpage>1376</lpage><pub-id pub-id-type="pmcid">PMC11250361</pub-id><pub-id pub-id-type="pmid">38858457</pub-id><pub-id pub-id-type="doi">10.1038/s41588-024-01787-7</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonioni</surname><given-names>A</given-names></name><etal/></person-group><article-title>Frontotemporal Dementia, Where Do We Stand? A Narrative Review</article-title><source>Int J Mol Sci</source><year>2023</year><volume>24</volume><elocation-id>11732</elocation-id><pub-id pub-id-type="pmcid">PMC10380352</pub-id><pub-id pub-id-type="pmid">37511491</pub-id><pub-id pub-id-type="doi">10.3390/ijms241411732</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quach</surname><given-names>H</given-names></name><etal/></person-group><article-title>Genetic adaptation and neandertal admixture shaped the immune system of human populations</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>643</fpage><lpage>656</lpage><elocation-id>e17</elocation-id><pub-id pub-id-type="pmcid">PMC5075285</pub-id><pub-id pub-id-type="pmid">27768888</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.09.024</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nédélec</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Genetic ancestry and natural selection drive population differences in immune responses to pathogens</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>657</fpage><lpage>669</lpage><elocation-id>e21</elocation-id><pub-id pub-id-type="pmid">27768889</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auton</surname><given-names>A</given-names></name><etal/></person-group><article-title>A global reference for human genetic variation</article-title><source>Nature</source><year>2015</year><volume>526</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="pmcid">PMC4750478</pub-id><pub-id pub-id-type="pmid">26432245</pub-id><pub-id pub-id-type="doi">10.1038/nature15393</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M-H</given-names></name><etal/></person-group><article-title>Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations</article-title><source>Cell</source><year>2020</year><volume>182</volume><fpage>1198</fpage><lpage>1213</lpage><elocation-id>e14</elocation-id><pub-id pub-id-type="pmcid">PMC7480402</pub-id><pub-id pub-id-type="pmid">32888493</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.045</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochoa</surname><given-names>D</given-names></name><etal/></person-group><article-title>The next-generation Open Targets Platform: reimagined, redesigned, rebuilt</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>D1353</fpage><lpage>D1359</lpage><pub-id pub-id-type="pmcid">PMC9825572</pub-id><pub-id pub-id-type="pmid">36399499</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkac1046</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanai</surname><given-names>I</given-names></name><etal/></person-group><article-title>Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>650</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">15388519</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagès</surname><given-names>Hervé</given-names></name></person-group><source>SNPlocs.Hsapiens.dbSNP144.GRCh38</source><year>2017</year></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>RH</given-names></name></person-group><article-title>RHReynolds/colochelpR: v0.99.1</article-title><source>Zenodo</source><year>2021</year><pub-id pub-id-type="doi">10.5281/zenodo.5011869</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Genes causing neurodegeneration are expressed in peripheral immune cells in a cell-type, cell-state and ancestry specific manner.</title><p><bold>a</bold>, Number of genes causing neurodegeneration expressed in multi-ancestry study of peripheral blood cells (Aquino et al<sup><xref ref-type="bibr" rid="R35">35</xref></sup>). <bold>b</bold>, Proportion of genes expressed in peripheral blood cells (14 AD, 13 PD and 5 FTD) that have an association with lymphocyte, monocyte, neutrophil and total white blood cell count (left-to-right, from Chen et al<sup><xref ref-type="bibr" rid="R53">53</xref></sup>). <bold>c</bold>, Results of differential gene expression analysis, showing genes significantly differentially expressed in blood cell lineages in European relative to African ancestry. Empty tile denotes no significant differential expression. <bold>d</bold> Heatmap showing proportion of gene expression of genes causing neurodegeneration across cell types and lineages in multi-ancestry study. The cell-state with maximal gene expression is shown, with expression represented as proportion of maximal expression per gene over all cell types. <bold>e</bold>, Column showing cell-type specificity of genes, with labels showing the cell-type with greatest gene expression, and shaded by τ-statistic (darker suggests greater specificity). <bold>f</bold>, Column showing cell-state specificity, where, for the cell-type that showed maximal expression for each gene, the label shows the exposure that caused the maximal expression (or ‘-’ where maximal expression was in unstimulated cells). Shading shows the τ-statistic of the labelled activation state compared to the other activations.</p></caption><graphic xlink:href="EMS200764-f001"/></fig><fig id="F2" position="float"><label>Fig 2</label><caption><title>Expression of PD genes in peripheral immune cells mediate risk of PD in an ancestry dependent manner.</title><p><bold>a</bold>, Colocalisation of <italic>LRRK2</italic> (top) and <italic>SNCA</italic> (bottom) between multi-ancestry eQTL and PD GWAS from European (left) and East Asian (right) ancestry. PPH3 measures discrete risk, PPH4 measures colocalised risk (significant colocalisation = posterior hypothesis &gt; 0.75, represented by the dashed line). <bold>b</bold>, Colocalisation of <italic>SNCA</italic> using eQTL and GWAS from East Asian ancestry.</p><p><bold>c-f</bold>, Locus analysis of significant colocalising signals between PD GWASs and eQTLs. Results from LRRK2 locus using European PD GWAS and multi-ancestry eQTL in SARS-CoV-2 treated monocytes, showing -log10(p values) (<bold>c</bold>) and betas (<bold>d</bold>). Results from <italic>SNCA</italic> locus using East Asian PD GWAS and East Asian eQTL in CD16+ monocytes, showing correlation of p-values (<bold>e</bold>) and beta values (<bold>f</bold>). Text shows Pearson’s correlation coefficient and p value, with beta plots also showing the regression line of best fit shaded with 95% confidence intervals.</p></caption><graphic xlink:href="EMS200764-f002"/></fig></floats-group></article>